CNTXContext Therapeutics Inc.

Nasdaq contexttherapeutics.com


$ 1.84 $ 0.10 (5.71 %)    

Friday, 03-May-2024 15:59:44 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 1.85
$ 1.68
$ 0.00 x 0
$ 0.00 x 0
$ 1.68 - $ 1.87
$ 0.47 - $ 1.88
1,197,178
na
29.54M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 12-02-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-context-therapeutics-lowers-price-target-to-4

HC Wainwright & Co. analyst Emily Bodnar maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and lowers the price ta...

 why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

 constellation-energy-battalion-oil-and-other-big-stocks-moving-higher-on-friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recordi...

 context-therapeutics-q3-eps-037-down-from-024-yoy

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.37) per share. This is a 54.17 percent decrease over losses...

 hc-wainwright--co-upgrades-context-therapeutics-to-buy-announces-5-price-target

HC Wainwright & Co. analyst Emily Bodnar upgrades Context Therapeutics (NASDAQ:CNTX) from Neutral to Buy and announces $...

 context-therapeutics-announces-preclinical-data-demonstrating-differentiated-and-active-profile-of-its-claudin-6-targeted-bispecific-antibody-ctim-76

CTIM-76 exhibits dose-proportional tumor responses and safety in preclinical modelsBenchmarking studies comparing CTIM-76 with ...

 why-aerwins-technologies-shares-are-trading-higher-by-around-90-here-are-20-stocks-moving-premarket

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies i...

 maxim-group-initiates-coverage-on-context-therapeutics-with-buy-rating-announces-price-target-of-4

Maxim Group analyst Jason McCarthy initiates coverage on Context Therapeutics (NASDAQ:CNTX) with a Buy rating and announces ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION